Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVO.L Regulatory News (AVO)

  • There is currently no data for AVO

Directorate Change

16 Dec 2011 16:58

RNS Number : 1861U
CareCapital Group plc
16 December 2011
 



16 December 2011

 

 

CareCapital Group Plc

 

("CareCapital" or "the Company")

 

Directorate change

 

Further to the announcement made on 1 September 2011, the Board of Care Capital, the AIM listed developer and investor in healthcare properties, is pleased to announce that Don Baladasan has been appointed as Finance Director of the Company.

 

Don Baladasan BSc (Econ) (aged 38) is a Member of the Chartered Institute of Management Accountants. He is the founder and director of Mataxis Ltd, which provides outsourced accounting services to SMEs and start ups. Previous roles include head of accounting development at Stemcor Holdings Limited, responsible for all accounting and treasury systems. . Mr. Baladasan held previous roles at BUPA Hospitals, Burson Marsteller and the Financial Times Group.

 

Additional disclosures pursuant to Schedule 2 (g) of the AIM Rules:

Current directorships:

CentralNic Registrar Ltd

GB.com Ltd

Mataxis Ltd

 

Previous directorships:

None

 

There is no other information that is required to be disclosed with regards to the appointment of Don Baladasan pursuant to Schedule 2 paragraph (g) of the AIM Rules.

 

Enquiries:

CareCapital Group Plc

Paul Stacey, Chief Executive

+44 (0) 20 7034 1949

Libertas Capital Corporate Finance Limited

Sandy Jamieson

+44 (0) 20 569 9650

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAKMMMZVVVGMZM
Date   Source Headline
4th Jul 20189:00 amRNSPrice Monitoring Extension
2nd Jul 20187:00 amRNSDirectorate Changes
27th Jun 20187:00 amRNSFinal Results
31st May 20187:00 amRNSUpdate on financing
29th May 20187:00 amRNSTechnological update
11th May 20184:35 pmRNSPrice Monitoring Extension
11th May 20187:00 amRNSUpdate on Distribution Agreement Payment
8th May 20187:00 amRNSUK assembly and testing site agreement
26th Apr 20181:50 pmRNSGPSL Research on Advanced Oncotherapy Plc
5th Apr 20187:00 amRNSHolding(s) in Company
3rd Apr 20189:43 amRNSUpdate on Distribution Agreement
12th Mar 20187:15 amRNSHardman & Co Research: Confidence greatly boosted
23rd Feb 20184:05 pmRNSHolding(s) in Company
16th Feb 20187:00 amRNSCompletion of the Subscription Agreement
23rd Jan 201811:48 amRNSResult of Meeting
12th Jan 20187:00 amRNSDirector dealing
28th Dec 20177:01 amRNSNotice of GM
28th Dec 20177:00 amRNSTechnological update
22nd Dec 201711:24 amRNSHolding(s) in Company
13th Dec 20174:25 pmRNSHolding(s) in Company
11th Dec 20172:02 pmRNSHardman Res.: Distribution deal & capital increase
7th Dec 20177:00 amRNSDistribution agreement and Equity Investments
29th Sep 20177:00 amRNSHalf-year Report
4th Sep 20177:00 amRNSTechnological update
1st Aug 20177:00 amRNSDirector Dealing
31st Jul 20177:00 amRNSTechnological milestones update - CCL units
19th Jul 20173:56 pmRNSResult of AGM
19th Jul 201710:16 amRNSFinancing facility by significant shareholders
5th Jul 20177:00 amRNSVideo and update on progress at Harley Street
26th Jun 20177:00 amRNSFinal Results
21st Jun 20177:00 amRNSConversion of Convertible Loan Notes
14th Jun 20177:00 amRNSAppointment of Senior VP of Medical Physics
13th Jun 20177:00 amRNSAdditional financing agreement and new appointment
12th Jun 20177:00 amRNSTechnological milestones update
5th Jun 20172:45 pmRNSUpdate on Bracknor financing
31st May 20174:41 pmRNSHolding(s) in Company
30th May 20177:00 amRNSHarley Street construction update
26th May 20176:23 pmRNSConversion of Convertible Loan Notes
26th May 20177:00 amRNSUpdate on Bracknor financing
24th May 20177:13 amRNSConversion of convertible loan notes
23rd May 201712:01 pmRNSHolding(s) in Company
18th May 20177:31 amRNSConversion of convertible loan notes
16th May 20179:02 amRNSConversion of loan notes
15th May 20171:01 pmRNSDirector Dealing
11th May 20177:00 amRNSDirector Dealing
8th May 20177:00 amRNSIssue of Equity & Director Shareholding
4th May 20177:05 amRNSHolding(s) in Company
3rd May 20171:29 pmRNSHolding(s) in Company
28th Apr 20177:00 amRNSUpdate on Bracknor financing
26th Apr 201711:18 amRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.